Hungarian AI drug discovery company Turbine has raised an additional EUR 5.5 million (USD 6 million) from MassMutual Ventures (MMV) in its extended Series A funding round, bringing the total Series A funds to EUR 25.5 million (USD 28 million). The previous Series A round closed in November 2022 .
The proceeds will be used to advance the company’s internal pipeline of therapeutic programs and further develop its AI-powered biology simulation platform to support more partnerships.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.